Markets:

Overview

News

Currencies

International

Treasuries

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of (NY:FMS)

23.03 +0.28 (+1.23%)

Streaming Delayed Price Updated: 2:11 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of

< Previous 1 2 3 4 Next >

Dialysis Player Fresenius Medical's Q4 Sales Hold Steady: Details ↗

February 20, 2024

Fresenius Medical Care Q4 2023 revenue: €4.9 billion. Patient volume growth is expected at 0.5%-2% in 2024.

Via Benzinga

Fresenius Medical Care: Q4 Earnings Insights ↗

February 20, 2024

Via Benzinga

A Preview Of Fresenius Medical Care's Earnings ↗

February 19, 2024

Via Benzinga

Fresenius Medical Care Hit By Major Data Breach: Half A Million Patients Potentially Affected ↗

December 06, 2023

Fresenius Medical Care (NYSE: FMS) said in a

Via Benzinga

Only Have $100? 3 No-Brainer Stocks to Buy Right Now ↗

November 28, 2023

The stock market is such a well-oiled, wealth-generating machine that investors can start with just $100 to buy these no-brainer stocks.

Via InvestorPlace

Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact? ↗

October 27, 2023

Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.

Via Investor's Business Daily

Why Shares of Fresenius Medical Jumped This Week ↗

July 14, 2023

The company announced that it will simplify its corporate structure.

Via The Motley Fool

A Bullish Sign Appears On Fresenius Medical Care's Chart ↗

March 13, 2023

Via Benzinga

Earnings Preview For Fresenius Medical Care ↗

February 21, 2023

Via Benzinga

Earnings Scheduled For February 20, 2024 ↗

February 20, 2024

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.

Via Benzinga

Stock Market Rallies, Hits Resistance; Novo Nordisk, JPMorgan, Exxon In Focus: Weekly Review ↗

October 13, 2023

The major indexes stalled at key levels amid weak breadth.

Via Investor's Business Daily

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 11, 2023

Via Benzinga

Why Dialysis Stocks Plunged Today ↗

October 11, 2023

Novo Nordisk indicated one of its diabetes drugs could also be used to treat kidney disease. Here's what investors need to know.

Via The Motley Fool

Why Shares of Fresenius Medical Care Were Dropping on Wednesday ↗

October 11, 2023

Positive trial news for a kidney failure drug could cut into business for dialysis therapies companies such as Fresenius.

Via The Motley Fool

What's Going On With Kidney Dialysis Provider Stocks Today? ↗

October 11, 2023

DaVita Inc (NYSE: DVA), Fresenius Medical Care AG (NYSE: FMS), and Baxter International Inc (NYSE: BAX) shares fel

Via Benzinga

Bear Of The Day: Fresenius Medical ↗

November 11, 2022

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally.

Via Talk Markets

Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 11, 2023

Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in...

Via Benzinga

Ozempic Is Moving a Bunch of Stocks Wednesday Morning ↗

October 11, 2023

Find out who the winners and losers are.

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 11, 2023

Via Benzinga

Why VOXX International Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

October 11, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

October 11, 2023

Pre-market stock movers are a hot topic on Wednesday morning and we're covering all of the latest news investors need to know about!

Via InvestorPlace

Silk Road Medical, E2open And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

October 11, 2023

U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 10, 2023

Via Benzinga

Cal-Maine Foods, A10 Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

October 04, 2023

U.S. stock futures traded mixed this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Fresenius Medical Expects Smaller Annual Income Decline Amid Easing Cost Inflation, Labor Shortages ↗

August 02, 2023

Fresenius Medical Care AG's (NYSE: FMS) Q2 adjusted operating income increased 41% Y/Y to €401 milli

Via Benzinga

Fresenius Medical Care: Q1 Earnings Insights ↗

May 09, 2023

Fresenius Medical Care (NYSE:FMS) reported its Q1 earnings results on Tuesday, May 9, 2023 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

eBay, Unity Software, Teladoc Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

February 23, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Fresenius Medical Care Q4 Profit Slips Despite Higher Revenue, Simplifies Structure ↗

February 22, 2023

Via Benzinga

3 Stocks With Dividends of 3% or More to Buy on the Dip ↗

November 14, 2022

Three underpriced healthcare stocks provide an opportunity.

Via The Motley Fool

Earnings Outlook For Fresenius Medical Care ↗

October 31, 2022

Fresenius Medical Care (NYSE:FMS) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.